Conference presentations

2018

  1. Im H-J, Ha S, Choi H, Park HR, Park KW, Lee DS, et al. Association of Parkinson’s Disease Symptom Laterality and 123I-FP-CIT SPECT after Deep Brain Stimulation. Journal of Nuclear Medicine. 2018;59:629.
  2. Bradshaw T, Perk T, Chen S, Im H-J, Cho S, Perlman S, et al. Deep learning for classification of benign and malignant bone lesions in [F-18]NaF PET/CT images. Journal of Nuclear Medicine. 2018;59:327.

 

2017

  1. NI D, Jiang D, Im H-J, Valdovinos H, Yu B, Barnhart T, et al. 89Zr-Labeled renal clearable polyoxometalate cluster for positron emission tomography imaging. Journal of Nuclear Medicine. 2017;58:672.
  2. Lee I, McMillan A, Hernando D, Kinner S, Im H-J, Reeder SB, et al. Comparison of FDG PET/CT and PET/MR for imaging of brown adipose tissue in normal subjects. Journal of Nuclear Medicine. 2017;58:1232.
  3. Lee I, Im H-J, Song C, Solaiyappan M, Cho S. Evaluation of FDG PET textural features for the prognosis of soft tissue sarcoma patients. Journal of Nuclear Medicine. 2017;58:19.
  4. Lee I, Im H-J, McCarten K, Schwartz C, Cole P, Kelly K, et al. Evaluation of inter-observer reliability and assessment of PET SUV-based quantification of 5-point Deauville score in FDG PET/CT in a COG pediatric high risk Hodgkin lymphoma trial (AHOD0831). Journal of Nuclear Medicine. 2017;58:639.
  5. Jiang D, Im H-J, England C, Ehlerding E, Graves S, Barnhart T, et al. ImmunoPET imaging of HER2 expression in ovarian cancer using 64Cu-labeled pertuzumab. Journal of Nuclear Medicine. 2017;58:689.
  6. Im H-J, McIlwain S, Ong I, Lee I, Song C, Shulkin B, et al. Prediction of response to neoadjuvant chemotherapy using machine learning algorithm trained by baseline FDG-PET textural parameters in osteosarcoma. Journal of Nuclear Medicine. 2017;58:44.

 

2016

  1. Perk T, Im H-J, Cho S, Perlman S, Liu G, Jeraj R. PET/CT metrics for differentiation of benign and malignant bone lesions in CRPC patients using [F-18]NaF PET/CT imaging. Journal of Nuclear Medicine. 2016;57:1428.
  2. Im H-J, Wu H, Yi Z, Wu J, Shulkin B, Cho S. Baseline Metabolic Tumor Volume Measured by FDG PET/CT Before Neoadjuvant Chemotherapy Predicts Survival in Pediatric Osteosarcoma. Journal of Nuclear Medicine. 2016;57:429.
  3. Im H-J, Solaiyappan M, Bradshaw T, Cho S. Validation of Multi-level Otsu Method to Define Metabolic Tumor Volume in Positron Emission Tomography. Journal of Nuclear Medicine. 2016;57:1405.
  4. Im H-J, Ibrahim N, Perk T, Jeraj R, Liu G, Cho S, et al. Diagnostic Strategy of 18F-NaF (NaF) PET/CT for Inconclusive Lesions in Patients with Metastatic Prostate Cancer. Journal of Nuclear Medicine. 2016;57:1559.
  5. England C, Kamkaew A, Valdovinos H, Im H-J, Barnhart T, Cai W. ImmunoPET imaging of insulin-like growth factor 1 receptor (IGF-1R) in pancreatic cancer. Journal of Nuclear Medicine. 2016;57:1348.
  6. England C, Im H-J, Chen F, Hernandez R, Cho S, Nickles R, et al. Radiolabeled long circulating nanoparticles for re-assessing the enhanced permeability and retention effect in peripheral arterial disease. Journal of Nuclear Medicine. 2016;57:65.

 

2015

  1. Lee S-P, Lee ES, Choi H, Im HJ, Paeng JC, Cheon GJ, et al. Diagnostic and Prognostic Implication of 11C-Pittsburgh B Positron Emission Tomography in AL Cardiac Amyloidosis. Journal of Nuclear Medicine. 2015;56:25.

 

2014

  1. Suh M, Im HJ, Choi H, Paeng JC, Cheon GJ, Kim CH, et al. Coronary flow reserve measured by 13N-ammonia PET for physiologic assessment of haemodynamically significant coronary vessels: Comparison with fractional flow reserve. Journal of Nuclear Medicine. 2014;55:522.
  2. Im HJ, Suh M, Choi H, Paeng JC, Cheon GJ, Kim CH, et al. Coronary flow reserve measured in 13N-ammonia myocardial PET for detection of significant in stent restenosis: Comparison with angiographic stenosis and fractional flow reserve. Journal of Nuclear Medicine. 2014;55:1766.
  3. Chun IK, Hwang DW, Kang H-J, Im HJ, Jeon WK, Lee DS. Functional change in rat with bilateral common carotid occlusion is apparently visualized by connectivity analysis with 18F-FDG PET. Journal of Nuclear Medicine. 2014;55:1812.
  4. Chun IK, Hwang DW, Im HJ, Jeon WK, Lee DS. Effect of isoflurane on rat brain metabolism assessed by 18F-FDG small animal PET with voxel-based approach. Journal of Nuclear Medicine. 2014;55:1803.

 

2013

  1. Im HJ, Paeng JC, Chung J-K, Lee DS. Relationship between quantitative parameters of 99mTc-sestamibi SPECT/CT, preoperative PTH, and volume of parathyroid adenoma. Journal of Nuclear Medicine. 2013;54:146.
  2. Im HJ, Choi H, Paeng JC, Cheon GJ, Lee DS. Quantitative measurement of metabolic status of visceral fat by simultaneous 18F FDG PET/MR. Journal of Nuclear Medicine. 2013;54:298.
  3. Choi H, Paeng JC, Cheon GJ, Im HJ, Chun IK, Chung J-K, et al. Development of a combined parameter on fusion images of 11C-methionine PET and diffusion-weighted MRI: Diagnostic value for tumor grading in brain tumors. Journal of Nuclear Medicine. 2013;54:1843.
  4. Choi H, Kim YK, Oh SW, Im HJ, Hwang DW, Lee Y-S, et al. In vivo imaging of mGluR5 using 11C-ABP688 in experimental animal model of epilepsy. Journal of Nuclear Medicine. 2013;54:248.

 

~2012

  1. Budiawan H, Im HJ, Paeng JC, Cheon GJ, Kang KW, Chung J-K, et al. Differentiating between metastatic and inflammatory lymph nodes in adenocarcinoma of the lung by heterogeneity of 18F-FDG uptake. Journal of Nuclear Medicine. 2013;54:1579.
  2. Park SY, Im Hj, Lee WW, Kim SE. Establishment of spleen scan in mice. Journal of Nuclear Medicine. 2012;53:1597.
  3. Im H-J, Kim Y-i, Lee JJ, Kim YK, Kim SE. Usefulness of combined metabolic-volumetric indices of FDG PET for the evaluation of neoadjuvant chemotherapy outcomes in breast cancer. Journal of Nuclear Medicine. 2011;52:200.
  4. Im H-J, Kim S-K, Kim T-S, Park S-Y. Prognostic value of retrocrural lymph node involvement revealed by FDG PET/CT in cervical cancer. Journal of Nuclear Medicine. 2011;52:145.
  5. Im H-J, Hwang DW, Lee HK, Jang J, Lee S, Youn H, et al. In vivo visualization of viable neural stem cells expressing high sensitive optical imaging reporters in mouse model of Parkinson’s disease. Journal of Nuclear Medicine. 2011;52:7.
  6. Im HJ, Kim CE, Kim YK, Kim SJ, Kim SE, Lee DS. Alteration of cerebral glucose metabolism in rat models of chronic neuropathic pain. Journal of Nuclear Medicine. 2010;51:1750.
  7. Im HJ, Chung J-K, Kang S-B, Lee DS. Retrocrural lymph node metastasis revealed by FDG PET/CT: A predictor of supra-diaphragmatic spread in ovarian cancer. Journal of Nuclear Medicine. 2010;51:17.
  8. Shim H-k, Kim S-k, Im H-j, Kang SH, Kim TS. Comparison with early and late dual-time FDG PET/CT scans after radiotherapy in head and neck cancer. Journal of Nuclear Medicine. 2009;50:1774.
  9. Kim S-k, Shim H-k, Im H-j, Kang SH, Kim TS. Comparison with FDG PET/CT and enhanced MR for hepatic metastases from colorectal cancer. Journal of Nuclear Medicine. 2009;50:287.
  10. Im HJ, Lim Ih, Paeng JC, Koo DH, Lee KE, Youn Y-K, et al. Influence of endoscopic total thyroidectomy on postoperative thyroid remnant. Journal of Nuclear Medicine. 2009;50:156.
  11. Im HJ, Kang SH, Kim TS, Min HS, Kang HG, Lee SH, et al. Prediction of chemotherapy response using combined volumetric and metabolic indices drawn from FDG-PET/CT in osteosarcoma patients. Journal of Nuclear Medicine. 2009;50:586.
광고